Amy Abernethy, the principal deputy commissioner and acting CIO of the Food and Drug Administration, discusses the agency’s plans to update its data strategy and technology to move with the speed of scientific advancement. Abernethy also explains the importance of leveraging innovative technology like AI and blockchain, migrating to the cloud, and public-private partnerships supporting the agency’s COVID-19 response efforts.
HealthCast
Season 1
Episode 23
29m listen
FDA’s Technology Modernization Vision
FDA is modernizing its technology infrastructure to accelerate scientific and regulatory decisions.
-
Amy Abernethy Principal Deputy Commissioner and Acting CIO FDA
Related Content
-
NOAA Secures the Seas with AI and Autonomy
Rear Adm. Chad Cary says his agency integrates emerging technology and systems to enhance marine domain awareness.
10m watch -
CMMC Needs to Adapt to Evolving Cyber Threats
Katie Arrington says DOD needs to strengthen dynamic cybersecurity in the age of AI and quantum.
13m listen -
Navy Lab's PROTEUS Provides AI-Powered Maritime Awareness
NRL's Alan Hope details how real-time data and AI are empowering agencies to track vessels, combat threats and enhance maritime domain awareness.
23m watch -
NCI Uses Wearables Data to Link Exercise to Cancer Risk
NCI finds a connection between low-intensity exercise and decreased risk of cancer through data collected from wearable technology.
9m listen
